References

Duncan MS, Freiberg MS, Greevy RA, Kundu S, Vasan RS, Tindle HA Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA. 2019; 322:(7)642-650 https://doi.org/10.1001/jama.2019.10298

Hippisley-Cox J, Coupland C, Vinogradova Y Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008; 336:(7659)1475-1482 https://doi.org/10.1136/bmj.39609.449676.25

Iacobucci G Fewer people are attending NHS health checks, show figures. BMJ. 2019; 367 https://doi.org/10.1136/bmj.l6098

Jackson G, Boon N, Eardley I Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010; 64:(7)848-857 https://doi.org/10.1111/j.1742-1241.2010.02410.x

Kuehn BM Evidence for HIIT Benefits in Cardiac Rehabilitation Grow. Circulation. 2019; 140:(6)514-515 https://doi.org/10.1161/CIRCULATIONAHA.119.042160

Lamb YN Inclisiran: First Approva. Drugs. 2021; 81:(3)389-395 https://doi.org/10.1007/s40265-021-01473-6

Lang SJ, Abel GA, Mant J, Mullis R Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. BMJ Open. 2016; 6:(3) https://doi.org/10.1136/bmjopen-2015-009984

Lean ME, Leslie WS, Barnes AC Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018; 391:(10120)541-551 https://doi.org/10.1016/S0140-6736(17)33102-1

Mach F, Baigent C, Catapano AL 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41:(1)111-188 https://doi.org/10.1093/eurheartj/ehz455

Mancia G, Rea F, Corrao G, Grassi G Two-drug combinations as first-step antihypertensive treatment. Circ Res. 2019; 124:(7)1113-1123 https://doi.org/10.1161/CIRCRESAHA.118.313294

National Institute for Health and Care Excellence. Cardiovascular risk assessment and lipid modification Quality standard 100. 2015. https://www.nice.org.uk/guidance/qs100/chapter/Quality-statement-3-Lifestyle-advice-for-primary-prevention (accessed 21 June 2021)

National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. 2019. https://www.nice.org.uk/guidance/ng136 (accessed 21 June 2021)

National Institute for Health and Care Excellence. Atrial fibrillation: diagnosis and management. 2021. https://www.nice.org.uk/guidance/ng196 (accessed 21 June 2021)

NHS England/Accelerated Access Collaborative. Summary of national guidance for lipid management for primary and secondary prevention of CVD. 2020. https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2020/04/lipid-management-pathway-guidance.pdf (accessed 21 June 2021)

NHS England. Improving physical ill-health and cardiovascular disease (CVD) prevention in people with severe mental illness. 2019. https://www.england.nhs.uk/rightcare/2019/03/21/improving-physical-ill-health-and-cardiovascular-disease-cvd-prevention-in-people-with-severe-mental-illness/ (accessed 21 June 2021)

NHS England. Network Contract DES. 2020. https://www.england.nhs.uk/primary-care/primary-care-networks/network-contract-des/ (accessed 21 June 2021)

Nordmann AJ, Nordmann A, Briel M Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166:(3)285-293 https://doi.org/10.1001/archinte.166.3.285

Schroeder EC, Franke WD, Sharp RL, Lee DC Comparative effectiveness of aerobic, resistance, and combined training on cardiovascular disease risk factors: A randomized controlled trial. PLoS One. 2019; 14:(1) https://doi.org/10.1371/journal.pone.0210292

Bempedoic Acid for LDL-C Lowering: What Do We Know?. 2020. https://www.acc.org/latest-in-cardiology/articles/2020/08/10/08/21/bempedoic-acid-for-ldl-c-lowering (accessed 21 June 2021)

Tulloch HE, Pipe AL, Els C, Clyde MJ, Reid RD Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. BMC Med. 2016; 14 https://doi.org/10.1186/s12916-016-0626-2

Waterall J, Greaves F, Kearney M, Fenton KA NHS Health Check: an innovative component of local adult health improvement and well-being programmes in England. J Public Health (Oxf). 2015; 37:(2)177-184 https://doi.org/10.1093/pubmed/fdv062

Health Matters: Preventing cardiovascular disease. 2019. https://publichealthmatters.blog.gov.uk/2019/02/14/health-matters-preventing-cardiovascular-disease/ (accessed 21 June 2021)

The 10-year CVD ambitions for England – one year on. 2020. https://publichealthmatters.blog.gov.uk/2020/02/06/the-10-year-cvd-ambitions-for-england-one-year-on/ (accessed 21 June 2021)

Understanding primary prevention of cardiovascular disease

02 July 2021
8 min read
Volume 32 · Issue 7

Abstract

Cardiovascular disease causes significant morbidity and mortality across the UK. Beverley Bostock looks at the role practice nurses can play in the primary prevention of this condition

Nurses working in general practice play an important role in identifying those at risk of developing cardiovascular disease (CVD) and implementing person-focused risk reduction strategies. The NHS Health Check programme was designed to identify people between the age of 40 and 74 years with risk factors for CVD. Nurses in general practice have a key role to play in encouraging people to attend Health Checks and helping people to understand the potential benefits of CVD risk assessment and reduction strategies. Lifestyle interventions and pharmacological management allow modifiable risk factors to be managed in an evidence-based and person-focused way.

Cardiovascular disease (CVD) is the cause of significant morbidity and mortality across the UK and is also linked to premature mortality. Nurses working in general practice play an important role in identifying those at risk of developing CVD and implementing person-focused risk reduction strategies. The NHS Health Check programme was introduced in 2009 to facilitate the early identification of people at high risk of CVD so that appropriate advice could be given, and action taken to reduce future cardiovascular events (Waterall et al, 2015). In 2019, Public Health England set out its CVD ambitions, and identified the importance of detecting atrial fibrillation (AF), hypertension and dyslipidaemia, and fine tuning the management of these risk factors to reduce CV events (Waterall, 2019). In this article, we discuss why CVD risk reduction is so important and demonstrate how to carry out a risk assessment and support people to address their risk factors. By the end of this article, you should have a greater awareness of:

Register now to continue reading

Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month